Volinanserin

Volinanserin
(IUPAC) ime
	(R)-(2,3-dimetoksifenil)-[1-[2-(4-fluorofenil)etil]-4-piperidil]metanol
Klinički podaci
Identifikatori
CAS broj	139290-65-6
ATC kod	nije dodeljen
PubChem	5311271
ChemSpider	4470782
UNII	EW71EE171J
ChEMBL	CHEMBL74355
Hemijski podaci
Formula	C22H28FNO3
Mol. masa	373,46 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3 ; Key: HXTGXYRHXAGCFP-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Volinanserin (MDL-100,907) je visoko selektivan antagonist 5-HT_2A receptor. On je u širokoj upotrebi u naučnim istraživanjima za istraživanje funkcije 5-HT_2A receptora.^[5]^[6]^[7] Volinanserin se isto tako ispituje kao potencijalni antipsihotik, antidepresiv i tretman za insomniju.^[8]^[9]^[10]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (November 1992). „5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine”. European Journal of Pharmacology 223 (1): 65–74. DOI:10.1016/0014-2999(92)90819-P. PMID 1362159.
↑ Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F (April 2009). „Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET”. Bioorganic & Medicinal Chemistry 17 (8): 2989–3002. DOI:10.1016/j.bmc.2009.03.021. PMID 19329329.
↑ Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (April 2009). „Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model”. Behavioral Neuroscience 123 (2): 382–96. DOI:10.1037/a0014592. PMID 19331461.
↑ Offord SJ, Wong DF, Nyberg S (August 1999). „The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action”. Journal of Clinical Pharmacology Suppl: 17S–24S. PMID 10434243.
↑ Marek GJ, Martin-Ruiz R, Abo A, Artigas F (December 2005). „The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine”. Neuropsychopharmacology 30 (12): 2205–15. DOI:10.1038/sj.npp.1300762. PMID 15886717.
↑ Teegarden BR, Al Shamma H, Xiong Y (2008). „5-HT(2A) inverse-agonists for the treatment of insomnia”. Current Topics in Medicinal Chemistry 8 (11): 969–76. DOI:10.2174/156802608784936700. PMID 18673166.

Povezano

Vanjske veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[pmid1362159-5] Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (November 1992). „5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine”. European Journal of Pharmacology 223 (1): 65–74. DOI:10.1016/0014-2999(92)90819-P. PMID 1362159.

[pmid19329329-6] Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F (April 2009). „Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET”. Bioorganic & Medicinal Chemistry 17 (8): 2989–3002. DOI:10.1016/j.bmc.2009.03.021. PMID 19329329.

[pmid19331461-7] Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (April 2009). „Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model”. Behavioral Neuroscience 123 (2): 382–96. DOI:10.1037/a0014592. PMID 19331461.

[pmid10434243-8] Offord SJ, Wong DF, Nyberg S (August 1999). „The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action”. Journal of Clinical Pharmacology Suppl: 17S–24S. PMID 10434243.

[pmid15886717-9] Marek GJ, Martin-Ruiz R, Abo A, Artigas F (December 2005). „The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine”. Neuropsychopharmacology 30 (12): 2205–15. DOI:10.1038/sj.npp.1300762. PMID 15886717.

[pmid18673166-10] Teegarden BR, Al Shamma H, Xiong Y (2008). „5-HT(2A) inverse-agonists for the treatment of insomnia”. Current Topics in Medicinal Chemistry 8 (11): 969–76. DOI:10.2174/156802608784936700. PMID 18673166.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]